The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma.

Hikmat Abdel-RazeqMohammad Ma'kosehAsem MansourRayan BaterRula AmarinAlaa AbufaraKhalid HalahlehMohammad ManassraMohammad AlrwashdehMohammad AlmomaniMais Zmaily

Published in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2022)

ThroLy RAM can identify patients with DLBCL at high risk for VTE. Model can be modified by dividing patients into two, rather than three risk groups, and further simplified by omitting neutropenia.

Keyphrases

diffuse large b cell lymphoma
venous thromboembolism
risk assessment
epstein barr virus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
direct oral anticoagulants
prognostic factors
human health
atrial fibrillation